Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials. Suter P, Greig R, Chan R, Lipworth B, et al. Respir Med 2025;248:108343.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suter P, Greig R, Chan R, Lipworth B, et al. Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials. Respir Med 2025;248:108343.
PMID: 40915326